XML 78 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisitions and Divestiture (Purchase Price Allocation) (Details) - USD ($)
$ in Millions
Feb. 15, 2019
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]      
Goodwill   $ 3,766.5 $ 3,679.4
Loxo Oncology, Inc.      
Business Acquisition [Line Items]      
Acquired IPR&D $ 4,670.0    
Finite-lived intangibles 980.0    
Deferred income taxes (1,032.8)    
Other assets and liabilities - net (26.4)    
Total identifiable net assets 4,590.8    
Goodwill 2,326.9    
Total consideration transferred - net of cash acquired $ 6,917.7    
Contract-based intangibles | Loxo Oncology, Inc.      
Business Acquisition [Line Items]      
Weighted average useful life 12 years    
Selpercatinib (LOXO-292) | Loxo Oncology, Inc.      
Business Acquisition [Line Items]      
Acquired IPR&D $ 4,600.0